About JaxBio
JaxBio is a company based in Netanya (Israel) founded in 2020 by Dror Feldheim, Joel Bar El, Shahar Zirkin, and Yuval Ebenstein. JaxBio has raised $6 million across 4 funding rounds from investors including European Union. JaxBio offers products and services including Blood Test and AI Platform. JaxBio operates in a competitive market with competitors including Abingdon Health, Genoptix, SkylineDX, Precipio Diagnostics and Biofluidica, among others.
- Headquarter Netanya, Israel
- Founders Dror Feldheim, Joel Bar El, Shahar Zirkin, Yuval Ebenstein
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6 M (USD)
in 4 rounds
-
Latest Funding Round
$2.73 M (USD), Grant
Jul 16, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of JaxBio
JaxBio offers a comprehensive portfolio of products and services, including Blood Test and AI Platform.
Enables fast and sensitive early detection of cancer via blood biomarkers.
Utilizes AI to identify cancer types and stages from blood samples.
Funding Insights of JaxBio
JaxBio has successfully raised a total of $6M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $2.73 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in JaxBio
JaxBio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for JaxBio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by JaxBio
Investment portfolio details for JaxBio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - JaxBio
Detailed financials for JaxBio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Jaxbio Comparisons
Peer comparison for JaxBio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of JaxBio
JaxBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abingdon Health, Genoptix, SkylineDX, Precipio Diagnostics and Biofluidica, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of immunoassays for diagnostic purposes
|
|
| Locked | Locked | Locked |
Oncology diagnostics and informatics services
|
|
| Locked | Locked | Locked |
Gene expression profiling tests are provided for personalized medicine.
|
|
| Locked | Locked | Locked |
Cancer diagnostics and second opinion tools are offered.
|
|
| Locked | Locked | Locked |
Liquid biopsy tests utilizing CTCs are provided for cancer detection.
|
|
| Locked | Locked | Locked |
Nanotechnology-based particle delivery platform is developed for oncology applications.
|
Detailed competitors of JaxBio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Jaxbio
Complete news archive for JaxBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about JaxBio
JaxBio was founded in 2020 and raised its 1st funding round 2 years after it was founded.
JaxBio is headquartered in Netanya, Israel. It is registered at Netanya, Central District, Israel.
JaxBio is a funded company, having raised a total of $6M across 4 funding rounds to date.
JaxBio was founded in 2020 in Netanya, Israel, within the biotechnology sector. An AI-based chip is developed by the company for analyzing genetic and epigenetic profiles. A set of biomarkers is provided to identify various cancer types. Diagnostic tests with a multi-cancer approach are supported through the chips features. Operations focus on advancing precision diagnostics in oncology.
JaxBio's top competitors include Abingdon Health, Precipio Diagnostics and SkylineDX.
JaxBio offers Blood Test and AI Platform.
JaxBio has 1 investor. Key investors include European Union.